Skip to main content

Comparing Everolimus vs Lanreotide

View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Everolimus Lanreotide
View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Everolimus Lanreotide
Prescription only

Prescribed for Neuroendocrine Tumors, Breast Cancer, Tuberous Sclerosis Complex, Brain Tumor, Organ Transplant - Rejection Prophylaxis, Pancreatic Cancer, Renal Angiomyolipoma, Renal Cell Carcinoma... View more

Prescription only

Prescribed for Neuroendocrine Tumors, Carcinoid Syndrome, Acromegaly. Lanreotide may also be used for purposes not listed in this medication guide.

Related suggestions
More about Everolimus More about Lanreotide
Ratings & Reviews

Everolimus has an average rating of 5.6 out of 10 from a total of 29 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 38% reported a negative effect.

Lanreotide has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect.

View all 29 reviews

View all 1 reviews

Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified.

View all Everolimus side effects

View all Lanreotide side effects
Drug Class
Generic Availability

Lower cost generic

Lower cost generic
Pricing and Coupons * Prices are without insurance
Quantity 28 each
Strength 2.5 mg
Per unit* $162.27
Cost* $4,543.50

View all Everolimus prices

Quantity 0.5 mL
Strength 120 mg/0.5 mL
Per unit* $5,308.44 - $14,959.66
Cost* $2,654.22 - $7,479.83

View all Lanreotide prices

Get free Discount Card

Get free Discount Card

Dosage Forms
  • Oral tablet
  • Oral tablet, dispersible
  • Subcutaneous solution
Brand Names
Afinitor, Afinitor Disperz, Torpenz, Zortress Somatuline Depot
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value.

35 hours

720 hours
CSA Schedule 1 View glossary of CSA terms
N
Not a controlled drug

Is not subject to the Controlled Substances Act.
N
Not a controlled drug

Is not subject to the Controlled Substances Act.
Pregnancy Category
D
Category D Positive evidence of risk

See the full pregnancy warnings document.
C
Category C Risk cannot be ruled out

See the full pregnancy warnings document.
Drug Interactions

A total of 547 drugs are known to interact with Everolimus:

  • 179 major drug interactions (686 brand and generic names)
  • 357 moderate drug interactions (937 brand and generic names)
  • 11 minor drug interactions (43 brand and generic names)

A total of 163 drugs are known to interact with Lanreotide:

  • 4 major drug interactions (8 brand and generic names)
  • 147 moderate drug interactions (482 brand and generic names)
  • 12 minor drug interactions (24 brand and generic names)
Alcohol/Food/Lifestyle Interactions
  • Grapefruit juice can increase the blood levels and effects of everolimus. You should not drink... View more
  • Lanreotide may affect the absorption of dietary nutrients and medications that you take by mouth... View more
Disease Interactions
First Approval Date

March 30, 2009

N/A
WADA Class View classifications

N/A

N/A
More Information
Patient Resources
Professional Resources
Related Treatment Guide

1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Compare Drugs

To view a report comparing 3 (or more) medications, please sign in or create an account.

Create an account Sign In